5-azauracil,
1,3,5-Triazine-2,4(1H,3H)-dione,
5-AZAURACIL,
71-33-0,
Allantoxaidin,
Allantoxaidine,
Oxaidin,
1H-1,3,5-triazine-2,4-dione,
5-Aza-2,4-dihydroxypyrimidine,
CCRIS 3442,
s-Triazine-2,4(1H,3H)-dione,
EINECS 200-750-0,
NSC 56901,
UNII-FSO760LQ2L,
FSO760LQ2L,
GEWRKGDRYZIFNP-UHFFFAOYSA-N,
1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione,
NSC56901,
dihydroxy-s-triazine,
s-Triazine-2,3H)-dione,
AC1Q6FW7,
AC1Q6GP1,
SCHEMBL127925,
1,3,5-triazine-2,4-diol,
AC1L1M69,
CTK2H9157,
GEWRKGDRYZIFNP-UHFFFAOYSA-,
DTXSID00221218,
KS-00000F1G,
BBL100011,
FCH991714,
MFCD00023157,
NSC-56901,
RW3793,
STL510951,
ZINC17315051,
1,5-Triazine-2,4(1H,3H)-dione,
AKOS000281203,
AKOS015854531,
DS-5277,
MCULE-2256730820,
AJ-70052,
AK126672,
s-Triazine-2,4(1H,3H)-dione (8CI),
1,3,5-Triazine-2,4(1H,3H)-dione #,
AX8102418,
LS-188088,
FT-0081116,
FT-0631307,
InChI=1/C3H3N3O2/c7-2-4-1-5-3(8)6-2/h1H,(H2,4,5,6,7,8),
Azauracil,
C3H3N3O2,
CID6275,
KST-1B8264,
C3-H3-N3-O2,
AR-1B6260,
RW1348,
CS-T-04482,
1,3,5-triazine-2,4(3H,5H)-dione,
74112-36-0,